New Drug Tariff Under Social Security
[Per Press Association—Copyright] WELLINGTON, This Day
Important alterations in the drug tariff are announced by the Minister for Health (Mr Nordmeyer). They will come into force on February 1. The new tariff sets out in some detail the substance or classes of substances that are accepted as a charge on the Social Security Fund, and those that are excluded.
Some of the substances now included, such as liver products administered by injection, and the sulphanilamide drugs and their derivatives, may be obtainable only under brand, but may nevertheless be supplied wholly or in part at the cost of the fund, provided they comply with a standard not lowe r than that described in the official monograph if there is one applicable. Patient to Pay. Extra Cost
In the case of more expensive brands, a patient must pay any cost in excess of the price allowed from the fund.
The amount of pharmaceutical requirements that may be ordered at the cost of the fund on any one prescription has been amended to provide tr'at in general only five days’ supply may be gathered and, if directed, this may be repeated once not later than 30 days after the date oi the presentation of the prescription. To provide for the requirements of patients suffering from chronic conditions, a medical practitioner may order, at the cost of the fund, a supply sufficient for not more than 30 days’ treatment, which may be supplied in the manner most convenient, but in the case of the sulphanilamide group, five days’ supply only may be given in one prescription.
Permanent link to this item
https://paperspast.natlib.govt.nz/newspapers/NA19420110.2.112
Bibliographic details
Northern Advocate, 10 January 1942, Page 7
Word Count
269New Drug Tariff Under Social Security Northern Advocate, 10 January 1942, Page 7
Using This Item
NZME is the copyright owner for the Northern Advocate. You can reproduce in-copyright material from this newspaper for non-commercial use under a Creative Commons New Zealand BY-NC-SA licence . This newspaper is not available for commercial use without the consent of NZME. For advice on reproduction of out-of-copyright material from this newspaper, please refer to the Copyright guide.